Fig A1. Breast cancer incidence, by type of risk.

Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers.

Transcriptional Control Leading to Clinical Outcomes in Breast Cancer Cases

Results of Random-Effects Logistic Regression Analysis to Predict

PDF) Prospective Multicenter Cohort Study to Refine Management Recommendations for Women at Elevated Familial Risk of Breast Cancer: The EVA Trial

Heribert Bieling's research works University of Bonn, Bonn (Uni Bonn) and other places

Computational pathology improves risk stratification of a multi-gene assay for early stage ER+ breast cancer

Unique evolutionary trajectories of breast cancers with distinct genomic and spatial heterogeneity

Tomography, Free Full-Text

Cancers, Free Full-Text

Description of the EVA Cohort

Christiane KUHL, Chair, RWTH Aachen University, Aachen, Department of Diagnostic and Interventional Radiology